EUVIMEDOpdag EUVIMED
Crossref

A MARCKS Effector Domain‐Derived Cytotoxic Peptide Induces Acute Tumor Cell Death

Yucai Wang, Yue Qiu, Decheng Liu, Hongyuan Zhang, Chenguang Xu iD

Cell Biochemistry and Function · 2025-11 · 43 (11)

DOI: 10.1002/cbf.70139 ↗

At a glance

Journal article in Cell Biochemistry and Function, published online on 2025-11-05. Written by Yucai Wang and 4 co-authors. Institution: Institute of Molecular Immunology, Department of Biotechnology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzh…. Major MEDLINE topics: Myristoylated Alanine-Rich C Kinase Substrate, Peptides, Antineoplastic Agents. Cited 1 times so far (Crossref); 37 references. Funded by: Chenguang Xu was supported by the National Natural Science Foundation of China (32170940, 82572100), the Guangdong Basic and Applied Basic Research Foundation….

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Peptide drugs, with their unique properties of specific therapeutic effects and minimal side effects, are a promising avenue in cancer treatment. The MARCKS effector domain (ED) peptide has been found to inhibit MARCKS function or induce cell death. In this study, we investigated the cytotoxic efficacy of the non‐phosphorylating MARCKS ED peptide with four serine (4S) of ED mutation to alanine (4 A) and with a transactivator of transcription (TAT) (termed 4A‐TAT) fusion to improve cell permeating. We found that the 4A‐TAT peptide caused acute and robust cytotoxicity against various tumor cell lines and had low toxicity to normal human B cells. Mechanistically, 4A‐TAT rapidly disrupts plasma membrane integrity via pore formation, leading to calcium dyshomeostasis and organelle dysfunction, and ultimately inducing non‐apoptotic cell death. In addition, the ED4A amino acid component is more critical than its order, and TAT is essential for the high sensitivity of cytotoxicity. Our study suggests that 4A‐TAT peptide shows acute and robust killing effects on tumor cells in vitro and in vivo, making it a potentially intriguing cytotoxic peptide for tumor treatment.

Subjects

MeSH terms (MEDLINE)

Myristoylated Alanine-Rich C Kinase SubstratePeptidesAntineoplastic AgentsHumansCell DeathCell Line, TumorAnimalsProtein DomainsMiceNeoplasms

Author keywords

4A‐TAT peptideCell deathLymphomaMARCKS effector domainmembrane disruption

Substances

Myristoylated Alanine-Rich C Kinase SubstratePeptidesAntineoplastic Agents

Authors and institutions

  • Institute of Molecular Immunology, Department of Biotechnology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.

ORCID profiles: Chenguang Xu

Funding

  • Chenguang Xu was supported by the National Natural Science Foundation of China (32170940, 82572100), the Guangdong Basic and Applied Basic Research Foundation…

Cite

APA

Wang, Y., Qiu, Y., Liu, D., Zhang, H., & Xu, C. (2025). A MARCKS Effector Domain‐Derived Cytotoxic Peptide Induces Acute Tumor Cell Death. Cell Biochemistry and Function, 43(11). https://doi.org/10.1002/cbf.70139

Vancouver

Wang Y, Qiu Y, Liu D, Zhang H, Xu C. A MARCKS Effector Domain‐Derived Cytotoxic Peptide Induces Acute Tumor Cell Death. Cell Biochemistry and Function. 2025;43(11). doi:10.1002/cbf.70139

BibTeX
@article{Wang2025,
  author = {Wang, Yucai and Qiu, Yue and Liu, Decheng and Zhang, Hongyuan and Xu, Chenguang},
  title = {A MARCKS Effector Domain‐Derived Cytotoxic Peptide Induces Acute Tumor Cell Death},
  journal = {Cell Biochemistry and Function},
  year = {2025},
  volume = {43},
  number = {11},
  doi = {10.1002/cbf.70139}
}
Start for free →